Inventor
EMMA MASTELLER
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07KPeptides29%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms7%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
PatentTitleYear
11,566,076Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected cancers202311,559,583Anti-CSF1R antibody and agonistic anti-CD40 antibody combination therapy for cancer202311,421,034Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancer202211,155,615Anti-ROR1 antibodies2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2023Patents assigned to FIVE PRIME THERAPEUTICS INC (4)· patent assignee history
2021Patents assigned to EUREKA THERAPEUTICS INC (1)· patent assignee history
2021–2023Based in US· patent location history
2022–2023Patents assigned to BRISTOL MYERS SQUIBB CO (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| FIVE PRIME THERAPEUTICS INC | 4 | 2021–2023 |
| BRISTOL MYERS SQUIBB CO | 2 | 2022–2023 |
| EUREKA THERAPEUTICS INC | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2021–2023 |